FDA recalls Ramipril 2.5 mg capsules for manufacturing control deviations
Lupin Pharmaceuticals is recalling Ramipril 2.5 mg capsules after sourcing the active ingredient from an unapproved vendor. Approximately 112,770 bottles were distributed to wholesalers nationwide.
- Product
- RAMIPRIL — RAMIPRIL (RAMIPRIL)
- Category
- Drug
- Distribution
- Distributed nationwide